Sysmex adds XQ-320 to its line of three-part diff analyzers
March 4, 2025—Sysmex America announced the expansion of its 3-part differential automated hematology analyzer line with the XQ-320 for CBC testing.
Webinars and Sponsored Roundtables — Register Now
Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
CAP TODAY
Diagnostic Medicine Consortium announced
March 3, 2025—The Diagnostic Medicine Consortium has officially launched, bringing together the Association for Pathology Informatics and Project Santa Fe Foundation and with the aim of adding other like-minded collaborating medical diagnostic societies.
Troubleshooting QC Errors with Unity Next Peer QC
Laboratory QC errors can impact patient results and significantly increase healthcare expenses. Your lab can minimize errors, provide more reliable patient results, and avoid costly reruns with Unity Next Peer QC. Explore how your lab can increase reliability in test results by comparing QC results with over 38,000 peers and resolve issues quickly by accessing peer reports on-demand. To Learn more/Watch now click here.
Q-linea nabs second contract in U.S. for ASTar
Feb. 26, 2025—Q-linea announced that it has signed a second commercial contract for its ASTar instrumentation in the United States.
Labcorp test for advanced solid tumors now for clinical use
Feb. 25, 2025—Labcorp announced that its Labcorp Plasma Complete is now available for clinical use.
Roche unveils sequencing by expansion technology
Feb. 24, 2025—Roche unveiled a proprietary sequencing by expansion (SBX) technology that offers ultra-rapid, high-throughput sequencing that is flexible and scalable for a broad range of applications, including whole genome sequencing, whole exome sequencing, and RNA sequencing.
Room to grow: tumor-germline sequencing
February 2025—Genetic profiling has long had proven winners in oncology: somatic testing of tumors, and germline testing for surveillance and to identify potentially affected relatives.
The shift from cotesting to primary HPV screening
February 2025—Eric Huang, MD, PhD, is the first to admit that when it came time to switch to primary HPV testing, his laboratory at the University of Washington faced fewer obstacles than most. Dr. Huang joined the university in 2018 as director of the cytopathology laboratory.
FDA clears Roche Elecsys sFlt-1/PlGF ratio for preeclampsia
Feb. 18, 2025—Roche announced that its Roche Elecsys sFlt-1/PlGF ratio for preeclampsia has received FDA 510(k) clearance.
In chemistry and more, what to know about new checklist edition
February 2025—In the 2024 accreditation program checklist edition, released Dec. 26, are new and revised requirements for chemistry, diagnostic immunology, and flow cytometry laboratories. Two of the flow cytometry requirements are now also in the anatomic pathology checklist.